The news around GLP-1s tends to read like a highlight reel
Patient assistance programs for eligible patients If your household income falls below certain thresholds, you may qualify for free medication through a Patient Assistance Program (PAP)
How are payors and providers balancing the high upfront costs of GLP-1s with delayed realization of long-term health benefits in value-based care models?
The 3 mg dose is NOT considered therapeutic
Any history of alcohol-related health problems , including liver disease, pancreatitis, gastritis, or previous attempts to reduce drinking Changes in drinking patterns since starting GLP-1 medication, whether increased or decreased consumption, or altered tolerance to alcohol Gastrointestinal symptoms and whether alcohol worsens nausea, vomiting, or other side effects Concerns about alcohol use disorder : If you're finding it difficult to control your drinking, your GP can arrange referral to specialist NHS alcohol services Your GP should provide personalised advice based on your individual circumstances, including other medications, comorbidities, and treatment goals
No, there are currently no GLP-1 patches licensed by the MHRA or approved by NICE for use in the United Kingdom
